Insulin improves well-being for selected elderly type 2 diabetic subjects.

Area of Science:

• Gerontology
• Endocrinology
• Diabetes Management

Background:

• Elderly patients with Type 2 diabetes often have poor glycemic control on oral agents.
• Assessing the impact of insulin therapy on patient-reported outcomes and caregiver burden is crucial.

Purpose of the Study:

• To evaluate the effects of insulin therapy on well-being, treatment satisfaction, mood, and carer strain in elderly Type 2 diabetic patients.
• To compare outcomes between patients initiating insulin and those continuing oral agents.

Main Methods:

• A study involving 30 elderly Type 2 diabetic patients with poor glycemic control on oral therapy.
• Assessment using the Short Form 36 (SF-36) health survey, Diabetes Treatment Satisfaction Questionnaire (DTSQ), and Geriatric Depression Scale.
• A comparison group of 10 poorly controlled patients continued oral agents.

Main Results:

• Insulin therapy led to significant improvements in mental health, role-emotional, role-physical, and vitality domains of the SF-36 after 4 weeks (P<0.05).
• Significant improvements were also observed in the DTSQ and Geriatric Depression Scale (P<0.01) at 4 weeks, sustained at 12 weeks.
• Carer strain decreased at 4 weeks, and no significant changes were noted in the comparison group.

Conclusions:

• Insulin treatment offers significant benefits in well-being, treatment satisfaction, and mood for selected elderly Type 2 diabetic patients.
• These improvements occur independently of significant glycemic control changes and do not increase carer strain.
• The SF-36 and DTSQ are effective tools for measuring treatment benefits in this patient population.